Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
American Heart Journal.
Times cited: 63
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction.
Circulation: Heart Failure.
Times cited: 113